YciB contributes to maintaining cell envelope integrity, a critical factor for bacterial survival under host-induced stress. Genomic analyses of Salmonella Paratyphi C reveal that this pathogen shares 89.78% gene similarity with S. Typhi but exhibits distinct adaptations, including plasmid degradation and pseudogene accumulation . YciB’s interaction with membrane components may facilitate these adaptive processes.
Functional Insights:
YciB homologs in S. Typhimurium (e.g., YciF) exhibit ferroxidase activity, mitigating oxidative stress by sequestering excess iron . While direct evidence for YciB’s enzymatic function is pending, structural similarities suggest analogous roles in metal homeostasis .
Comparative genomics highlight convergent evolution among typhoid-associated Salmonella, where proteins like YciB may drive host-specific adaptations .
| Genome Feature | Chromosome | Plasmid (pSPCV) |
|---|---|---|
| Size | 4,833,080 bp | 55,414 bp |
| G+C Content | 52.2% | 52.8% |
| Pseudogenes | 149 | 3 |
| yciB Location | Chromosomal (STM1735) | Absent |
Structural Studies: High-resolution crystallography to elucidate metal-binding sites and oligomerization mechanisms.
Functional Assays: Validate ferroxidase or septation activity using knockout models.
Therapeutic Exploration: Assess YciB’s immunogenicity for vaccine development, akin to O-antigen conjugates .
KEGG: sei:SPC_1994
YciB (probable intracellular septation protein A) is an inner membrane protein with five transmembrane domains, as confirmed through membrane topology studies. In Escherichia coli, the protein spans the inner membrane and plays a critical role in maintaining cell envelope integrity. The amino acid sequence of yciB (179 amino acids in E. coli O81) suggests a highly hydrophobic protein with multiple membrane-spanning regions, consistent with its localization and function .
YciB participates in several essential cellular processes including cell elongation and cell division through protein-protein interactions with respective complexes. Research using bacterial two-hybrid systems has demonstrated that yciB interacts with various proteins involved in these processes. Additionally, deletion studies have shown that yciB-deficient mutants exhibit increased susceptibility to low osmolarity environments, suggesting its involvement in maintaining membrane integrity under osmotic stress conditions .
While the search results don't provide direct sequence comparison between S. paratyphi C and E. coli yciB, comparative genomic analyses show considerable conservation of inner membrane proteins across enteric bacteria. The functional characterization of yciB in E. coli provides a foundation for understanding its role in Salmonella species. Given the genetic relationship between these enteric bacteria, the core functional domains of yciB are likely preserved, though species-specific variations may exist related to host adaptation patterns .
E. coli-based expression systems have proven effective for recombinant yciB production, as evidenced by the successful expression of His-tagged full-length yciB. When expressing membrane proteins like yciB, it's critical to consider expression conditions that minimize toxicity while maximizing protein yield. For example, commercial recombinant yciB is produced with N-terminal His-tags in E. coli expression systems, demonstrating the feasibility of this approach .
Affinity chromatography using His-tag purification methods is the primary approach for obtaining high-purity yciB. According to available data, purification protocols can achieve >90% purity as determined by SDS-PAGE. The purified protein is typically prepared as a lyophilized powder in Tris/PBS-based buffer containing 6% trehalose at pH 8.0 to maintain stability. For downstream applications, reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL is recommended, with 5-50% glycerol added for long-term storage stability .
As a membrane protein, yciB requires careful handling during reconstitution to maintain its native conformation. The recommended approach involves brief centrifugation of the lyophilized protein before opening, followed by reconstitution in deionized sterile water. Addition of glycerol (typically 50% final concentration) helps maintain protein stability during storage at -20°C/-80°C. Repeated freeze-thaw cycles should be avoided, with working aliquots stored at 4°C for no more than one week to preserve functional integrity .
Bacterial two-hybrid systems have successfully demonstrated yciB interactions with cell division proteins. This technique was instrumental in identifying that yciB interacts with various proteins involved in cell elongation and cell division complexes. For researchers investigating novel interaction partners, pull-down assays using recombinant His-tagged yciB combined with mass spectrometry could provide comprehensive identification of interacting proteins. Co-immunoprecipitation experiments with antibodies against known division proteins can also validate specific interactions in vivo .
Generalized polarization (GP) assays using the fluorescent dye Laurdan provide quantitative measurements of membrane fluidity changes associated with yciB function. This methodology has been successfully employed to demonstrate that yciB dcrB double mutants exhibit increased lipid ordering (decreased fluidity) compared to wild-type cells. The GP values are inversely correlated with membrane fluidity, making this a valuable technique for assessing how yciB mutations impact membrane physical properties. Control experiments using known membrane fluidizers like benzyl alcohol can validate the assay's sensitivity and reliability .
Analysis of lipoprotein processing defects can be performed through a combination of:
Western blot analysis to detect different forms of lipoproteins (e.g., Lpp)
Subcellular fractionation to determine lipoprotein localization
Monitoring expression of stress response systems (Cpx and Rcs)
Complementation studies with known lipoprotein processing enzymes (e.g., Lgt)
These approaches have revealed that yciB deficiency, particularly in combination with dcrB deletion, leads to inefficient lipid modification at the first step of lipoprotein maturation catalyzed by Lgt. This results in mislocalization of outer membrane lipoproteins to the inner membrane .
Suppressor mutation analysis has proven valuable in understanding yciB function, particularly in the context of yciB dcrB synthetic lethality. Several effective approaches include:
Deletion of lpp (outer membrane lipoprotein)
Removal of peptidoglycan-lipoprotein linkages
Overexpression of Lgt (catalyzes first step in lipoprotein maturation)
Deletion of skp (increases σE activity and enhances MicL sRNA amounts)
These genetic approaches have revealed that yciB dcrB synthetic lethality primarily results from inappropriate peptidoglycan-inner membrane linkages mediated by mislocalized Lpp, highlighting critical pathways for suppression analysis .
Distinguishing direct from indirect effects of yciB deletion requires a multi-faceted approach:
Comparative analysis of single (yciB) and double (yciB dcrB) mutants
Complementation studies with wild-type or mutant yciB variants
Analysis of stress response activation patterns
Temporal studies of phenotypic manifestations
For example, research has shown that while Cpx pathway activation occurs in both yciB single and yciB dcrB double mutants, Rcs activation and Lpp mislocalization are predominantly observed in the double mutant. This suggests that some phenotypes (e.g., Cpx activation) are direct consequences of yciB deletion, while others (e.g., lipoprotein maturation defects) emerge only when both yciB and dcrB are absent .
Low osmolarity and low temperature conditions significantly exacerbate yciB-related phenotypes. YciB deletion mutants show increased susceptibility to low osmolarity environments, suggesting its role in maintaining cell envelope integrity under these conditions. Additionally, dcrB null mutants are not viable when grown at low temperatures, conditions known to affect membrane fluidity. These observations indicate that yciB function becomes particularly critical under environmental stresses that impact membrane physical properties and homeostasis .
While specific comparative data on yciB function across Salmonella serovars is limited in the provided research, genomic studies indicate that S. paratyphi C shares greater genetic similarity with S. choleraesuis than with S. typhi or S. paratyphi A. Of the 4,640 genes identified in S. paratyphi C, 4,346 are shared with S. choleraesuis (primarily a swine pathogen), while only 4,008 are shared with the human-adapted S. typhi. This suggests that yciB function and regulation may be more similar between S. paratyphi C and S. choleraesuis, reflecting their closer evolutionary relationship despite different host adaptation patterns .
Evolutionary analysis reveals that typhoid-causing Salmonella serovars (including S. paratyphi C) evolved through convergent rather than divergent evolution. The specific selective pressures during adaptation to human hosts likely influenced the evolution of membrane proteins like yciB. Comparative genomic analysis shows that S. paratyphi C diverged from a common ancestor with S. choleraesuis through the accumulation of genomic novelty during human adaptation. This is reflected in differential nucleotide substitutions and distinct sets of pseudogenes between these closely related lineages. The greater number of non-synonymous (dN) than synonymous (dS) substitutions between S. paratyphi C and S. choleraesuis suggests rapid selection for amino acid changes that facilitated host adaptation .
YciB represents a promising antimicrobial target due to several favorable characteristics:
Essential role in maintaining cell envelope integrity, particularly under stress conditions
Synergistic relationship with other membrane proteins (e.g., DcrB)
No homologs in mammalian cells, reducing off-target effects
Involvement in fundamental cellular processes like cell division
Researchers could develop small molecule inhibitors that disrupt yciB's interactions with cell division proteins or alter its membrane topology. Alternatively, peptide-based approaches targeting the transmembrane domains could disrupt its function. The synthetic lethality observed between yciB and dcrB also suggests that combination therapies targeting both proteins could be particularly effective against Salmonella infections .
YciB likely plays significant roles in bacterial stress response and potentially antimicrobial resistance through:
Maintenance of cell envelope integrity under osmotic stress
Involvement in lipoprotein maturation pathways
Impact on membrane fluidity and lipid homeostasis
Activation of envelope stress response systems (Cpx, Rcs)
The altered membrane fluidity observed in yciB mutants might affect the uptake or efflux of antimicrobial compounds. Additionally, defects in lipoprotein processing could impact the assembly of efflux pumps or other resistance mechanisms that depend on properly localized lipoproteins. Further research specifically targeting the relationship between yciB function and antimicrobial susceptibility profiles could reveal important mechanistic insights .
Advanced structural biology approaches would significantly enhance understanding of yciB function:
Cryo-electron microscopy to determine the high-resolution structure of yciB within the membrane
Molecular dynamics simulations to model how yciB interacts with lipids and alters membrane properties
NMR studies of isolated domains to identify interaction surfaces
Cross-linking mass spectrometry to map the interactome of yciB in vivo
These approaches could reveal how the five transmembrane domains are arranged, identify key residues involved in protein-protein interactions, and elucidate the mechanism by which yciB influences membrane fluidity and lipoprotein processing. Understanding the structural basis of yciB function would also facilitate rational design of inhibitors targeting this protein .
Expression of membrane proteins like yciB presents several significant challenges:
Toxicity to host cells due to membrane insertion disrupting normal function
Protein misfolding and aggregation during overexpression
Low yields compared to soluble proteins
Difficulties in maintaining native conformation during purification
Researchers can address these challenges by:
Using tightly controlled inducible expression systems
Optimizing growth temperatures (typically lower than for soluble proteins)
Including membrane-mimicking detergents during cell lysis and purification
Exploring fusion partners that enhance solubility
Attempting expression in cell-free systems with supplied lipids or detergents
The complex and potentially redundant functions of yciB create challenges in phenotypic analysis that can be addressed through:
Creating conditional mutants (temperature-sensitive or inducible depletion)
Combining mutations in synthetic lethal screens to reveal functional relationships
Using stress conditions (osmotic, temperature) that exacerbate phenotypes
Employing sensitive readouts for envelope stress (reporter fusions to stress-responsive promoters)
Conducting temporal analyses following yciB depletion to distinguish primary from secondary effects
The synthetic lethality observed between yciB and dcrB illustrates how combining mutations can reveal functional relationships that are not apparent in single mutants, highlighting the value of genetic interaction screens .
When interpreting yciB functional studies, researchers should be aware of several common pitfalls:
Attributing indirect effects to direct yciB function (e.g., stress responses triggered by envelope defects)
Overlooking strain-specific variations in phenotypes
Failing to account for growth conditions that might mask or exacerbate phenotypes
Misinterpreting complementation studies if expression levels differ from native conditions
Overlooking compensatory mechanisms that mask phenotypes in single mutants
For example, research has shown that while Cpx activation occurs in yciB single mutants, more severe phenotypes like lipoprotein maturation defects are only observed in yciB dcrB double mutants. This illustrates how single-gene studies might miss important functional aspects revealed through synthetic genetic approaches .
Several emerging technologies hold promise for advancing understanding of yciB dynamics in living cells:
Super-resolution microscopy techniques (PALM, STORM) to visualize yciB localization and dynamics during cell division
CRISPR interference (CRISPRi) for precise temporal control of yciB expression
Proximity labeling approaches (BioID, APEX) to map the dynamic interactome of yciB
Single-molecule tracking to monitor yciB diffusion and interactions in the membrane
Microfluidics combined with time-lapse microscopy to analyze yciB function under changing environmental conditions
These approaches would provide unprecedented insights into how yciB localizes, interacts with other proteins, and responds to environmental changes in real-time within living bacterial cells .
Systems biology approaches could integrate yciB function into broader cellular networks through:
Network analysis of genetic interactions to position yciB within functional pathways
Multi-omics integration (transcriptomics, proteomics, lipidomics) to understand the global impact of yciB perturbation
Flux balance analysis to model how yciB affects cell envelope biogenesis
Computational modeling of membrane protein interactions and dynamics
These integrative approaches could reveal how yciB functions within the complex network of proteins involved in cell envelope synthesis, cell division, and stress response pathways. Understanding these relationships would provide a more comprehensive view of how yciB contributes to cellular homeostasis and adaptability .
Beyond basic research, recombinant yciB might find applications in several biotechnological contexts:
Development of bacterial surface display systems leveraging yciB's membrane integration properties
Creation of attenuated live vaccine strains using controlled yciB expression
Engineering membrane vesicles with modified yciB for drug delivery applications
Development of biosensors for detecting envelope stress or antimicrobial compounds
Protein engineering to create chimeric membrane proteins with novel functions